Biotech Advancements Accelerate Drug Development; Novel Neuroprotectants and Clot-Busters Target Ischemia’s Impact
Biotech innovation is revolutionizing the brain ischemia drug market, with companies developing novel compounds that target the disease’s specific mechanisms—from clot formation to neuronal damage. Unlike traditional therapies, these drugs aim to not only dissolve clots but also protect brain cells during ischemia, reducing long-term disability. This focus on biological specificity...
0 Commenti
0 condivisioni
424 Views